Your browser doesn't support javascript.
loading
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders.
Patel, Yash; Parker, Nadine; Shin, Jean; Howard, Derek; French, Leon; Thomopoulos, Sophia I; Pozzi, Elena; Abe, Yoshinari; Abé, Christoph; Anticevic, Alan; Alda, Martin; Aleman, Andre; Alloza, Clara; Alonso-Lana, Silvia; Ameis, Stephanie H; Anagnostou, Evdokia; McIntosh, Andrew A; Arango, Celso; Arnold, Paul D; Asherson, Philip; Assogna, Francesca; Auzias, Guillaume; Ayesa-Arriola, Rosa; Bakker, Geor; Banaj, Nerisa; Banaschewski, Tobias; Bandeira, Cibele E; Baranov, Alexandr; Bargalló, Núria; Bau, Claiton H D; Baumeister, Sarah; Baune, Bernhard T; Bellgrove, Mark A; Benedetti, Francesco; Bertolino, Alessandro; Boedhoe, Premika S W; Boks, Marco; Bollettini, Irene; Del Mar Bonnin, Caterina; Borgers, Tiana; Borgwardt, Stefan; Brandeis, Daniel; Brennan, Brian P; Bruggemann, Jason M; Bülow, Robin; Busatto, Geraldo F; Calderoni, Sara; Calhoun, Vince D; Calvo, Rosa; Canales-Rodríguez, Erick J.
  • Patel Y; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Parker N; Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
  • Shin J; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Howard D; Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
  • French L; The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Thomopoulos SI; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Pozzi E; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Abe Y; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles.
  • Abé C; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Anticevic A; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Alda M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Aleman A; Department of Psychiatry, Yale University, New Haven, Connecticut.
  • Alloza C; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Alonso-Lana S; University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, Groningen, the Netherlands.
  • Ameis SH; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Spain.
  • Anagnostou E; FIDMAG Germanes Hospitalàries Research Foundation, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Catalonia, Spain.
  • McIntosh AA; The Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Arango C; Department of Pediatrics University of Toronto, Ontario, Canada.
  • Arnold PD; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, Scotland.
  • Asherson P; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM.
  • Assogna F; The Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Auzias G; Social, Genetic and Developmental Psychiatry Centre; Institute of Psychiatry, Psychology and Neuroscience; King's College London, London, England.
  • Ayesa-Arriola R; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Bakker G; INT UMR 7289, Aix-Marseille Université, CNRS, Aix-en-Provence, France.
  • Banaj N; Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria; Centro de Investigación Biomédica en Red de Salud Mental, Santander, Spain.
  • Banaschewski T; Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University, the Netherlands.
  • Bandeira CE; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Baranov A; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • Bargalló N; Department of Genetics, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Bau CHD; The Research Institute of Pediatrics and Child Health of the Central Clinical Hospital of the Russian Academy of Sciences of the Ministry of Science and Higher Education of the Russian Federation, Moscow, Russia.
  • Baumeister S; Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Baune BT; Department of Genetics, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Bellgrove MA; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • Benedetti F; University of Münster, Department of Psychiatry, Münster, Germany.
  • Bertolino A; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
  • Boedhoe PSW; Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Boks M; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy.
  • Bollettini I; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neuroscience, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Del Mar Bonnin C; Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Department of Psychiatry, Utrecht, the Netherlands.
  • Borgers T; Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Borgwardt S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
  • Brandeis D; University of Münster, Department of Psychiatry, Münster, Germany.
  • Brennan BP; Department of Psychiatry, University of Basel, Basel, Switzerland.
  • Bruggemann JM; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
  • Bülow R; McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
  • Busatto GF; School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.
  • Calderoni S; Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Calhoun VD; Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Calvo R; Department of Developmental Neuroscience - IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Canales-Rodríguez EJ; Department of Clinical and Experimental Medicine, University of Pisa.
JAMA Psychiatry ; 78(1): 47-63, 2021 Jan 01.
Article en En | MEDLINE | ID: mdl-32857118
ABSTRACT
IMPORTANCE Large-scale neuroimaging studies have revealed group differences in cortical thickness across many psychiatric disorders. The underlying neurobiology behind these differences is not well understood.

OBJECTIVE:

To determine neurobiologic correlates of group differences in cortical thickness between cases and controls in 6 disorders attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and schizophrenia. DESIGN, SETTING, AND

PARTICIPANTS:

Profiles of group differences in cortical thickness between cases and controls were generated using T1-weighted magnetic resonance images. Similarity between interregional profiles of cell-specific gene expression and those in the group differences in cortical thickness were investigated in each disorder. Next, principal component analysis was used to reveal a shared profile of group difference in thickness across the disorders. Analysis for gene coexpression, clustering, and enrichment for genes associated with these disorders were conducted. Data analysis was conducted between June and December 2019. The analysis included 145 cohorts across 6 psychiatric disorders drawn from the ENIGMA consortium. The numbers of cases and controls in each of the 6 disorders were as follows ADHD 1814 and 1602; ASD 1748 and 1770; BD 1547 and 3405; MDD 2658 and 3572; OCD 2266 and 2007; and schizophrenia 2688 and 3244. MAIN OUTCOMES AND

MEASURES:

Interregional profiles of group difference in cortical thickness between cases and controls.

RESULTS:

A total of 12 721 cases and 15 600 controls, ranging from ages 2 to 89 years, were included in this study. Interregional profiles of group differences in cortical thickness for each of the 6 psychiatric disorders were associated with profiles of gene expression specific to pyramidal (CA1) cells, astrocytes (except for BD), and microglia (except for OCD); collectively, gene-expression profiles of the 3 cell types explain between 25% and 54% of variance in interregional profiles of group differences in cortical thickness. Principal component analysis revealed a shared profile of difference in cortical thickness across the 6 disorders (48% variance explained); interregional profile of this principal component 1 was associated with that of the pyramidal-cell gene expression (explaining 56% of interregional variation). Coexpression analyses of these genes revealed 2 clusters (1) a prenatal cluster enriched with genes involved in neurodevelopmental (axon guidance) processes and (2) a postnatal cluster enriched with genes involved in synaptic activity and plasticity-related processes. These clusters were enriched with genes associated with all 6 psychiatric disorders. CONCLUSIONS AND RELEVANCE In this study, shared neurobiologic processes were associated with differences in cortical thickness across multiple psychiatric disorders. These processes implicate a common role of prenatal development and postnatal functioning of the cerebral cortex in these disorders.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Trastorno por Déficit de Atención con Hiperactividad / Trastorno Bipolar / Expresión Génica / Corteza Cerebral / Trastorno Depresivo Mayor / Desarrollo Fetal / Trastorno del Espectro Autista / Desarrollo Humano / Trastorno Obsesivo Compulsivo Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Trastorno por Déficit de Atención con Hiperactividad / Trastorno Bipolar / Expresión Génica / Corteza Cerebral / Trastorno Depresivo Mayor / Desarrollo Fetal / Trastorno del Espectro Autista / Desarrollo Humano / Trastorno Obsesivo Compulsivo Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article